Vytrus Biotech, a CataloniaBio & HealthTech member, closed 2020 with record turnover of €1.7 million, up 40% from 2019.
The audited annual accounts of this industrial biotechnology firm based in Terrassa (Barcelona) reflect a 200% increase in operating profit (EBITDA) for a total of €591,000.
This year, Vytrus has continued international expansion of its business based on the development, production and sale of plant-based active ingredients for the cosmetic and healthcare sectors.
Vytrus is one of the 10 companies chosen by CataloniaBio & HealthTech to take part in the first BIOMED ScaleUP corporate growth programme with mentors Xavier Marcet, Marc Fernández and Alejandro Santana from Lead To Change (LTC).
Photo: Albert Jané, co-founder and CEO of Vytrus Biotech, at one of the BIOMED ScaleUP sessions last May.
Comments